all the information, none of the junk | biotech • healthcare • life sciences

Quidel OKs $25M in Share Buybacks

Xconomy San Diego — 

San Diego-based Quidel (NASDAQ: QDEL), the maker of diagnostic tests for flu and other infectious diseases, said today its board has authorized the company to buy back an extra $25 million worth of its shares. The company was previously authorized to repurchase about $26 million worth of shares, and the board allowed extra buybacks to counter the dilutive effect of granting equity compensation to employees.